tlooto
Sign up
Medicine

Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease.

C. Martin, E. Burnet, A. Ronayette-Preira, P. de Carli, J. Martin, L. Delmas, B. Prieur, P. Burgel

2021.5.17Respiratory Medicine and Research

DOI: 10.1016/j.resmer.2021.100829

tlooto Summary

After initiation of elexacaftor-tezacaftor, CF patients with advanced disease reported rapid and positive physical, psychological and social effects, which translated into improved quality of life and the formulation of new life goals.

Abstract

Abstract is not available.

Citation format

MARTIN, C., et al. Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease. Respiratory Medicine and Research, 2021, 80: 100829.